A Phase II Study of Campath-1H in Children With Acute Lymphoblastic Leukemia in Second or Greater Relapse or Twice Induction Failure
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Alemtuzumab (Primary) ; Mercaptopurine; Methotrexate
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2007 Status changed from in progress to completed.
- 05 Sep 2005 New trial record.